Most Clicked AdvaMed SmartBrief Stories
1. Device tax will hurt businesses, individuals and the economy
AdvaMed SmartBrief | May 29, 2012
The 2.3% medical device excise tax will harm businesses and continued medical innovation, according to this editorial. It will have a negative impact on innovation at a time when Europe, Asia and Israel are striving to pass the U.S. as leaders in the life sciences. Congress is expected to consider legislation repealing the device tax soon, and a bill in the House has 238 sponsors. Wall Street Journal, The (05/28)
2. Doctors remove foot-long blood clot without open-heart surgery
AdvaMed SmartBrief | May 24, 2012
Cardiologists in Texas used a suction cannula to take a 12-inch blood clot from a woman's heart without resorting to open-heart surgery. Doctors said the clot originated as a deep vein thrombosis, and the patient will be treated with anti-coagulants to prevent a recurrence of the condition. KXAS-TV (Dallas-Fort Worth) (05/22)
3. Greatbatch to move corporate headquarters to Texas
AdvaMed SmartBrief | May 23, 2012
Greatbatch plans to transfer its headquarters to Frisco, Texas, in a quest to bring the company closer to academic research centers and leading medical device firms. The company will retain its production, offices and research and development operations in western New York, and no changes are planned for its more than 700 workers there, CEO Thomas Hook said. Dallas Morning News (free content), The (05/22)
4. Covidien unit offers $1.25 billion in senior notes
AdvaMed SmartBrief | May 23, 2012
Covidien International Finance, a wholly-owned unit of Covidien, plans to sell $1.25 billion in senior notes due in 2015 and 2022 in an offering that could be completed by May 30. The company will use the proceeds to repay its outstanding senior notes due in October and support general corporate functions. Reuters (05/22)
5. Personal monitoring devices will lead wireless health market by 2016
AdvaMed SmartBrief | May 24, 2012
An IMS Research report projects that the wireless medical technology market will be driven primarily by tools aimed at helping consumers track their own health, accounting for more than 80% of such devices by 2016. More than 50 million wireless devices are estimated to be shipped for consumer health monitoring in five years, with a fewer geared for telehealth use. Healthcare Informatics online (05/23)
6. Calif. weight loss device firm gets $2.75 million boost
AdvaMed SmartBrief | May 25, 2012
Vibrynt has secured $2.75 million in a round of financing targeted at $5.5 million. The startup, which is a spinoff of California medtech incubator ExploraMed, is working on a device that could help obese patients lose weight less invasively. MedCityNews.com (05/24)
7. HeartWare's cardiac pump gains expanded approval in Europe
AdvaMed SmartBrief | May 24, 2012
HeartWare has earned CE Mark approval to expand the use of its heart ventricular assist device for long-term treatment of all patients vulnerable to unresponsive, end-stage heart failure. The company is awaiting U.S. approval for a similar "destination therapy" indication of the device. MassDevice.com (Boston) (05/23)
8. Needleless injection device gaining impetus from pharma companies
AdvaMed SmartBrief | May 29, 2012
MIT researchers have created a jet-injection device that can deliver drugs through the skin without the need for needle pricks and in a highly controlled manner. The experimental device is said to be inciting interest from Sanofi and other large pharmaceutical companies for administering drugs at injection sites on various parts of the body, as well as other potential applications. Mass High Tech (Boston) (05/25)
9. Minn. remote monitoring device firm secures about $13 million
AdvaMed SmartBrief | May 24, 2012
Healthsense has obtained more than $13 million in a round of financing from strategic backers. The Mendota Heights, Minn.-based company is the maker of eNeighbor, a device that combines motion and contact sensors with Wi-Fi technology to remotely track seniors in their homes, assisted living areas, skilled nursing venues or community living spaces. MedCityNews.com (05/22)
10. AngioDynamics finalizes $355M buyout of Navilyst
AdvaMed SmartBrief | May 23, 2012
AngioDynamics has completed a deal to acquire Navilyst Medical for $355 million. The deal is expected to allow AngioDynamics to build a strong platform for future expansion, double its market share for vascular access devices and create critical mass in the peripheral vascular space. AuntMinnie.com (free registration) (05/22)
Sign up for AdvaMed SmartBrief
